Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.45 |
| ▸ | KAT6A | Q92794 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.42 |
| ▸ | CCR8 | P51685 | 1/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.42 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dipyridyl SCHEMBL15796588 | 0.88 | KDM4E (0.56) | CYP2A6TRPV1KDM4ELMNACYP1A2 | |
| Trifluoromethanesulfonic Acid SCHEMBL2391328 | 0.83 | CYP2A6 (0.47) | CYP2A6TRPV1KAT6AKDM4ELMNA | |
| Trifluoromethanesulfonic Acid SCHEMBL2391337 | 0.83 | CYP2A6 (0.47) | CYP2A6TRPV1KAT6AKDM4ELMNA | |
| Trifluoromethanesulfonic Acid SCHEMBL29983374 | 0.81 | KDM4E (0.43) | KDM4ELMNACYP1A2POLBCCR1 | |
| Trifluoromethanesulfonic Acid SCHEMBL14655597 | 0.80 | CYP2A6 (0.51) | CYP2A6KAT6AKDM4ELMNAPOLB | |
| SCHEMBL301762 | 0.80 | KDM4E (0.65) | CYP2A6KDM4ELMNACYP1A2POLB | |
| SCHEMBL354271 | 0.80 | KDM4E (0.65) | CYP2A6KDM4ELMNACYP1A2POLB | |
| SCHEMBL3985205 | 0.80 | KDM4E (0.65) | CYP2A6KDM4ELMNACYP1A2POLB | |
| SCHEMBL6831244 | 0.80 | KDM4E (0.65) | CYP2A6KDM4ELMNACYP1A2POLB | |
| SCHEMBL51343 | 0.80 | KDM4E (0.65) | CYP2A6KDM4ELMNACYP1A2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106366130-B | Phosphorescent material | 通用显示公司 | 2021-07-09 | — | — | CN | disclosed |
| CN-106366130-A | Phosphorescent materials | 通用显示公司 | 2017-02-01 | — | — | CN | disclosed |
| US-9540329-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-01-10 | — | — | US | disclosed |
| CN-102858910-B | phosphorescent material | 通用显示公司 | 2016-09-14 | — | — | CN | disclosed |
| US-9175211-B2 | Phosphorescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2015-11-03 | — | — | US | disclosed |
| EP-2542644-B1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2015-09-09 | — | — | EP | disclosed |
| US-20140021447-A1 | Diarylamino Substituted Metal Complexes | UNIVERSAL DISPLAY CORPORATION (US) | 2014-01-23 | — | — | US | disclosed |
| EP-2542644-A1 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2013-01-09 | — | — | EP | disclosed |
| CN-102858910-A | Phosphorescent material | UNIVERSAL DISPLAY CORP | 2013-01-02 | — | — | CN | disclosed |
| WO-2011109042-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-09-09 | — | — | WO | disclosed |
| US-20110215710-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140021447-A1 | Diarylamino Substituted Metal Complexes | OCIAD1, OXA1L, OCIAD2 | CYP2A6 3108/4885TRPV1 781/4885KAT6A 1766/4885 |
| US-20110215710-A1 | PHOSPHORESCENT MATERIALS | NUDC, P2RY4, P2RY6 | CYP2A6 2761/4885TRPV1 156/4885KAT6A 4320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.